Fonte: Analytical Biochemistry. Unidade: FMRP
Assuntos: METALOPROTEINASES, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANNELLO, Ferdinando et al. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, v. 374, n. 1, p. 56-63, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ab.2007.11.020. Acesso em: 06 nov. 2024.APA
Mannello, F., Tanus-Santos, J. E., Meschiari, C. A., & Tonti, G. A. (2008). Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, 374( 1), 56-63. doi:10.1016/j.ab.2007.11.020NLM
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020Vancouver
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020
